DNM2 and metachromatic leukodystrophy: In the latter role, for studies of metachromatic leukodystrophy and Niemann-Pick type C, cytoskeletal proteins, such as CSF tau, GFAP, and neurofilament light chain (NfL), were elevated at baseline and decreased with treatment, correlating with clinical improvements [36,37].